Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.
Publication
, Journal Article
Kohli, P; Cannon, CP
Published in: Nat Rev Cardiol
December 20, 2011
Major advances in the diagnosis of acute coronary syndromes (ACS) have occurred in 2011, but physicians treating ACS still walk the tightrope between efficacy and bleeding. Key publications have shed light on this delicate balance and heralded a new era of novel oral anticoagulants for the treatment of ACS.
Duke Scholars
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
December 20, 2011
Volume
9
Issue
2
Start / End Page
69 / 71
Location
England
Related Subject Headings
- Troponin
- Risk Factors
- Retrospective Studies
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Incidence
- Humans
- Hemorrhage
- False Positive Reactions
- Drug Therapy, Combination
Citation
APA
Chicago
ICMJE
MLA
NLM
Kohli, P., & Cannon, C. P. (2011). Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding. Nat Rev Cardiol, 9(2), 69–71. https://doi.org/10.1038/nrcardio.2011.206
Kohli, Payal, and Christopher P. Cannon. “Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.” Nat Rev Cardiol 9, no. 2 (December 20, 2011): 69–71. https://doi.org/10.1038/nrcardio.2011.206.
Kohli P, Cannon CP. Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding. Nat Rev Cardiol. 2011 Dec 20;9(2):69–71.
Kohli, Payal, and Christopher P. Cannon. “Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.” Nat Rev Cardiol, vol. 9, no. 2, Dec. 2011, pp. 69–71. Pubmed, doi:10.1038/nrcardio.2011.206.
Kohli P, Cannon CP. Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding. Nat Rev Cardiol. 2011 Dec 20;9(2):69–71.
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
December 20, 2011
Volume
9
Issue
2
Start / End Page
69 / 71
Location
England
Related Subject Headings
- Troponin
- Risk Factors
- Retrospective Studies
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Incidence
- Humans
- Hemorrhage
- False Positive Reactions
- Drug Therapy, Combination